Latest News
TikTok rejects Meta ads urging firm to join landmark child safety settlement: report
The rejected video ad featured a voiceover pressuring TikTok and YouTube to take action, Axios reported, citing sources familiar with the matter. TikTok informed Meta on Wednesday that it wouldn't run
Pentair plc (PNR) Notice of October 2, 2026 Application Deadline for Class Action Lawsuit
San Francisco, California--(Newsfile Corp. - September 11, 2026) - Hagens Berman Sobol Shapiro LLP alerts investors in Pentair plc (NYSE: PNR) that a securities fraud class action lawsuit filed agains
Kaplan Fox Announces a Securities Class Action Against Hertz Global Holdings, Inc. (HTZ) - Lead Plaintiff Deadline is September 22, 2026
New York, New York--(Newsfile Corp. - September 11, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hertz Global Holdings, Inc. ("Hertz" or the "Compan
Wix.com (WIX) Faces Securities Class Action Amid Scrutiny Over Vibe Coding Transition, Competitive and Financial Positioning - Hagens Berman
San Francisco, California--(Newsfile Corp. - September 11, 2026) - Wix.com Ltd. (NASDAQ: WIX) faces a securities class action in the wake of mid-May's massive 27% drop in the price of the company's sh
PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and Approximately 18% Stock Decline - Investors May Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP
San Francisco, California--(Newsfile Corp. - September 11, 2026) - Hagens Berman Sobol Shapiro LLP alerts investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) that a securities class action has
Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
BENSALEM, Pa., Sept. 11, 2026 /PRNewswire/ -- The Law Offices of Howard G.
Kaplan Fox Encourages Unicycive Therapeutics, Inc. (UNCY) Investors with Significant Losses to Contact the Firm Before November 2, 2026
New York, New York--(Newsfile Corp. - September 11, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Unicycive Therapeutics, Inc. ("Unicycive" or the "C
Kaplan Fox & Kilsheimer LLP Notifies EquipmentShare.Com Inc (EQPT) Investors of an Approaching Securities Class Action Deadline on September 21, 2026
New York, New York--(Newsfile Corp. - September 11, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against EquipmentShare.Com Inc ("EquipmentShare" or the "Co
Hugging Face CEO says asking Anthropic researcher ‘about AI extinction risk is like asking your AC guy about climate change'
Hugging Face CEO Clement Delangue isn't here for the Jacob Coxon discourse. Coxon went viral after posting that he resigned from Anthropic due to concerns about AI's risks.
Elite 9-10% Yielding Monthly Dividend Machines To Buy On The Dip
High-yielding investments that pay out cash flow monthly can be powerful passive income machines. When they are on sale and have a track record of total return outperformance, they are even more compe
BABA INVESTOR DEADLINE: Alibaba Group Holding Limited Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit
San Francisco, California--(Newsfile Corp. - September 11, 2026) - Hagens Berman Sobol Shapiro LLP urges Alibaba Group Holding Limited (NYSE: BABA) investors who suffered substantial losses submit the
INV INVESTOR DEADLINE: Innventure, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit
San Francisco, California--(Newsfile Corp. - September 11, 2026) - Innventure, Inc. (NASDAQ: INV) and certain executives face a securities class action lawsuit after its stock price cratered 55% on Au
CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before September 28, 2026 Deadline
San Francisco, California--(Newsfile Corp. - September 11, 2026) - Hagens Berman Sobol Shapiro LLP-a national plaintiffs' rights law firm with a premier securities practice group-notifies investors in
INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. (REGN) Investors with Substantial Losses Have Opportunity to Lead the Regeneron Class Action Lawsuit Before September 14, 2026 Deadline
San Francisco, California--(Newsfile Corp. - September 11, 2026) - Hagens Berman Sobol Shapiro LLP alerts investors in Regeneron Pharmaceuticals (NASDAQ: REGN) that a securities class action lawsuit h
Kaplan Fox Urges Primoris Services Corporation (PRIM) Investors Seeking Recovery to Contact the Firm Before September 21, 2026
New York, New York--(Newsfile Corp. - September 11, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Primoris Services Corporation ("Primoris" or the "C
Cogent Communications Holdings Securities Fraud Class Action Result of Undisclosed Demand and Backlog Issues and Approximately 29% Stock Decline - Investors May Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP
San Francisco, California--(Newsfile Corp. - September 11, 2026) - Hagens Berman Sobol Shapiro LLP alerts investors in Cogent Communications Holdings (NASDAQ: CCOI) that a securities class action has
NYSE president touts Texas' 'pro-business environment' as stock exchange competition grows
The Texas Stock Exchange scores its first major corporate listings as the NYSE expands into Dallas, intensifying competition for public companies and U.S. capital markets.
Lam Research Lifts 2026 WFE Outlook as AI Demand Strains Fab Capacity
Lam Research NASDAQ: LRCX executives said the semiconductor equipment industry remains constrained by available clean-room capacity despite a higher outlook for wafer-fabrication equipment spending, c
NEW YORK CAR DEALERS REMEMBER 9/11 - HOW THEY CAME TOGETHER FOR NEW YORK
/PRNewswire/ -- Twenty-five years after the attacks on the World Trade Center on September 11, 2001, the Greater New York Automobile Dealers Association
Exelixis Stock Slips as FDA Delays Cancer Drug Review, Analyst Weighs In
On Friday, the U.S. Food and Drug Administration (FDA) extended the review period for Exelixis Inc.‘s (NASDAQ:EXEL) new drug application (NDA) for zanzalintinib, in combination with atezolizumab, for